⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29093728 | 0.84 | CYP2C19 (1.00) | — | |
| SCHEMBL28575504 | 0.84 | CYP2C19 (1.00) | — | |
| SCHEMBL337864 | 0.84 | CYP2C19 (1.00) | — | |
| SCHEMBL29093071 | 0.84 | CYP2C19 (1.00) | — | |
| SCHEMBL28581632 | 0.84 | CYP2C19 (1.00) | — | |
| SCHEMBL713394 | 0.84 | CYP2C19 (1.00) | — | |
| SCHEMBL27556706 | 0.80 | CYP2C19 (0.92) | — | |
| SCHEMBL8370084 | 0.79 | CYP2C19 (0.62) | — | |
| SCHEMBL17760625 | 0.77 | CYP2C19 (0.71) | — | |
| SCHEMBL659682 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240426814-A1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-12-26 | — | — | US | disclosed |
| US-12111310-B2 | Pretreatment agent in non-agglutination assays | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2024-10-08 | — | — | US | disclosed |
| CN-117105769-B | Preparation method of ethyl 2-bromopropionate | 山东顺成化学有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117105769-A | Preparation method of ethyl 2-bromopropionate | 山东顺成化学有限公司 | 2023-11-24 | — | — | CN | disclosed |
| US-20230176481-A1 | FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-06-08 | — | — | US | disclosed |
| US-20230160880-A1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2023-05-25 | — | — | US | disclosed |
| US-11592439-B2 | Pretreatment agent in non-agglutination assays | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2023-02-28 | — | — | US | disclosed |
| US-20200217839-A1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2020-07-09 | — | — | US | disclosed |
| US-20190128877-A1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2019-05-02 | — | — | US | disclosed |
| EP-3080604-B1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC (US) | 2019-05-01 | — | — | EP | disclosed |
| US-20160313310-A1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2016-10-27 | — | — | US | disclosed |
| EP-3080604-A1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | Siemens Healthcare Diagnostics Inc. (US) | 2016-10-19 | — | — | EP | disclosed |
| WO-2015089172-A1 | PRETREATMENT AGENT IN NON-AGGLUTINATION ASSAYS | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2015-06-18 | — | — | WO | disclosed |